{"entity":{"type":"insider","cik":"0001454276","url":"/insider/0001454276","json_url":"/insider/0001454276.json","name":"Moore Terrence O","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":2,"first":"2017-02-16","last":"2017-02-23","span_basis":"filed_date"},"name_variants":[{"name":"Moore Terrence O","source":"filing","n_filings":2,"first_seen":"2017-02-16","last_seen":"2017-02-23"}],"transactions":[{"id":4879447,"accession":"0001415889-17-000308","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-17-000308","line_url":"/filing/0001415889-17-000308#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001454276","owner_name":"Moore Terrence O","owner_display_name":"Moore Terrence O","owner_url":"/insider/0001454276","role":"Officer (EVP, CHIEF COMMERCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (EVP, CHIEF COMMERCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7856.0,"shares_display":"7,856","price_per_share":39.65,"price_display":"39.65","price_state":"stated","total_value":311490.4,"total_display":"311,490.40","total_whole":"311,490","shares_owned_after":1671.0,"shares_owned_after_display":"1,671","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-21","filed_date":"2017-02-23","scope":"insider"},{"id":4096600,"accession":"0001415889-17-000282","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001415889-17-000282","line_url":"/filing/0001415889-17-000282#line-8","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001454276","owner_name":"Moore Terrence O","owner_display_name":"Moore Terrence O","owner_url":"/insider/0001454276","role":"Officer (EVP, CHIEF COMMERCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (EVP, CHIEF COMMERCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":66752.0,"shares_display":"66,752","price_per_share":39.8807,"price_display":"39.88","price_state":"stated","total_value":2662116.4864,"total_display":"2,662,116.49","total_whole":"2,662,116","shares_owned_after":1671.0,"shares_owned_after_display":"1,671","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-16","filed_date":"2017-02-16","scope":"insider"},{"id":4096590,"accession":"0001415889-17-000282","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-17-000282","line_url":"/filing/0001415889-17-000282#line-4","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001454276","owner_name":"Moore Terrence O","owner_display_name":"Moore Terrence O","owner_url":"/insider/0001454276","role":"Officer (EVP, CHIEF COMMERCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (EVP, CHIEF COMMERCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1700.0,"shares_display":"1,700","price_per_share":39.65,"price_display":"39.65","price_state":"stated","total_value":67405.0,"total_display":"67,405.00","total_whole":"67,405","shares_owned_after":1671.0,"shares_owned_after_display":"1,671","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-15","filed_date":"2017-02-16","scope":"insider"},{"id":4096585,"accession":"0001415889-17-000282","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-17-000282","line_url":"/filing/0001415889-17-000282#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001454276","owner_name":"Moore Terrence O","owner_display_name":"Moore Terrence O","owner_url":"/insider/0001454276","role":"Officer (EVP, CHIEF COMMERCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (EVP, CHIEF COMMERCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":89088.0,"shares_display":"89,088","price_per_share":39.6863,"price_display":"39.69","price_state":"stated","total_value":3535573.0944,"total_display":"3,535,573.09","total_whole":"3,535,573","shares_owned_after":1671.0,"shares_owned_after_display":"1,671","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-14","filed_date":"2017-02-16","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":4,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":4},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001070494","name":"ACADIA PHARMACEUTICALS INC","url":"/issuer/0001070494","role":"Officer (EVP, CHIEF COMMERCIAL OFFICER)","n_filings":2,"first_seen":"2017-02-16","last_seen":"2017-02-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001454276","retrieved_at":"2026-08-22T14:23:11+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}